Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2016 > Volume 25 Number 4 July 2016 > CASE REPORTS > Implantation of a SAPIEN 3 Valve in a Patient with Pure Aortic Regurgitation

Implantation of a SAPIEN 3 Valve in a Patient with Pure Aortic Regurgitation

Jan-Philipp Minol1,3, Verena Veulemans2, Tobias Zeus2, Alexander Blehm1

1Department of Cardiovascular Surgery, University Hospital, Düsseldorf, Germany
2Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany
3Electronic correspondence: phil.minol@gmx.de
Transcatheter aortic valve implantation (TAVI) is an emerging treatment for high-risk patients with aortic stenosis. Aortic regurgitation is considered to be a relative contraindication for transcatheter procedures, as a non-calcified aortic annulus poses the risk of an insufficient anchoring of the transcatheter aortic valve prosthesis. Herein is described the case of a patient who suffered from  recurrent aortic valve regurgitation after valve-sparing repair, and which was successfully treated by the transcatheter implantation of an Edwards SAPIEN 3™ prosthesis. This case report demonstrated the suitability of this prosthesis to treat pure aortic valve regurgitation, without excessive oversizing of the valve.

The Journal of Heart Valve Disease 2016;25:498-500


Implantation of a SAPIEN 3 Valve in a Patient with Pure Aortic Regurgitation

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.